Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 13, 2008

High Cholesterol Good for Hepatitis C Treatment?

Having higher levels of “bad” low-density lipoprotein (LDL) cholesterol is associated with a better response to hepatitis C (HCV) treatment in people infected with both HIV and HCV, say the authors of a study published in the May 11 issue of AIDS. This raises the question of whether a problematic side effect of many antiretroviral (ARV) drugs—increases in LDL—may actually be advantageous for people living with HIV undergoing treatment for HCV.

In people infected with HCV, but not HIV, studies have found that having a higher total cholesterol level and higher levels of LDL cholesterol is associated with having a sustained virologic response (SVR) to HCV treatment. An SVR is defined as an undetectable HCV viral load six months after completing HCV treatment. José del Valle, MD, from the Hospital Universitario de Valme in Sevilla, Spain, and his colleagues set out to determine whether the same thing would be true in people coinfected with HIV and HCV. From a cohort of 3,564 coinfected patients, del Valle’s team analyzed data from 339 who had received HCV treatment.

In all, 39 percent of the patients who were treated achieved an SVR. People with a higher LDL cholesterol level (above 100 mg/dL) were more likely to have an SVR. This result was statistically significant, meaning that the difference was too great to have occurred by chance. Total cholesterol, however, did not influence whether people had an SVR. Given the beneficial impact of higher LDL on HCV treatment, del Valle’s team concludes that further analysis of the use of various ARV drugs most likely to elevate LDL levels should be conducted.

Search: low-density lipoprotein, LDL, cholesterol, hepatitis C, HCV, Jose del Valle


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

Samuel, Washington DC, 2008-05-14 10:42:40
Well for someone that is going to undergo treatment for Hep C soon it is a slight ray of sun considering the treatment is not fun. I just learned that my cholestrol has gone up after being so good for years. We need all the help that we can get.

comments 1 - 1 (of 1 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy